{
    "article_id": "PMC9022943",
    "article_text_type": "abstract",
    "article_filtered_sentences": [
        "Primary objectives were to assess associations between (i) excision repair cross-complementing 1 (ERCC1) expression with progression-free survival (PFS), and (ii) plasma VEGF A (VEGF-A) with PFS in patients with previously untreated mCRC receiving mFOLFOX6-BV or FOLFIRI-BV."
    ],
    "registry_id": "NCT01374425",
    "registry_primary_outcomes": [
        "Progression-free survival (PFS) as determined by the investigator using RECIST, v1.1 , Time from randomization (baseline) to documented disease progression or death on study, whichever occurs first"
    ],
    "labels": {
        "POS_identif_possible": "Yes",
        "PO_switch": "No",
        "PO_not_reported_registry": "No",
        "PO_not_reported_publication": "No",
        "POS_timeframe_metric": "No",
        "Description": ""
    },
    "article_bio_outcomes": [
        {
            "sentence_nb": 0,
            "tokens": [
                "Primary",
                "objectives",
                "were",
                "to",
                "assess",
                "associations",
                "between",
                "(",
                "i",
                ")",
                "excision",
                "repair",
                "cross-complementing",
                "1",
                "(",
                "ERCC1",
                ")",
                "expression",
                "with",
                "progression-free",
                "survival",
                "(",
                "PFS",
                ")",
                ",",
                "and",
                "(",
                "ii",
                ")",
                "plasma",
                "VEGF",
                "A",
                "(",
                "VEGF-A",
                ")",
                "with",
                "PFS",
                "in",
                "patients",
                "with",
                "previously",
                "untreated",
                "mCRC",
                "receiving",
                "mFOLFOX6",
                "-",
                "BV",
                "or",
                "FOLFIRI-BV",
                "."
            ],
            "labels": [
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O",
                "O",
                "O",
                "O",
                "O",
                "B-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "I-PrimaryOutcome",
                "O"
            ]
        }
    ],
    "article_outcomes_text": [
        "plasma VEGF A ( VEGF-A ) with PFS in patients with previously untreated mCRC receiving mFOLFOX6 - BV or FOLFIRI-BV",
        "excision repair cross-complementing 1 ( ERCC1 ) expression with progression-free survival ( PFS )"
    ],
    "article2article_connections": [
        [
            0,
            1,
            false
        ]
    ],
    "filtered_article_outcomes": [
        "plasma VEGF A ( VEGF-A ) with PFS in patients with previously untreated mCRC receiving mFOLFOX6 - BV or FOLFIRI-BV",
        "excision repair cross-complementing 1 ( ERCC1 ) expression with progression-free survival ( PFS )"
    ],
    "article2registry_connections": [
        {
            "article_index": 0,
            "registry_index": 0,
            "similar": false
        },
        {
            "article_index": 1,
            "registry_index": 0,
            "similar": true
        }
    ]
}